University of Toronto researchers have developed a method that can rapidly screen human stem cells and better control what they will become – a technology that could be used for regenerative medicine and drug development.
The findings are published in this week’s issue of the journal Nature Methods.
“The work allows for a better understanding of how to turn stem cells into clinically useful cell types more efficiently,” said Emanuel Nazareth, a PhD student at U of T’s Institute of Biomaterials & Biomedical Engineering (IBBME). The research comes out of the lab of Professor Peter Zandstra, Canada Research Chair in Bioengineering at U of T.
Continue reading at UofT News.